Legislation of clinical antibiotic use in China.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

60 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. Epidemiology of pathogens and antimicrobial resistance of nosocomial urinary tract infections in patients with spinal cord injuries in China: A systematic review and meta-analysis.The journal of spinal cord medicine · 2023
   Pooled it
2. Risk factors for antibiotic resistance development in healthcare settings in China: a systematic review.Epidemiology and infection · 2021
   Pooled it
3. Protocol for a pragmatic cluster randomised controlled trial for reducing irrational antibiotic prescribing among children with upper respiratory infections in rural China.BMJ open · 2016
   Trial
4. Artificial intelligence predicts healthcare workers' antibiotic use intentions from psychological and behavioral measures across multiple theories.Scientific reports · 2026
   Article
5. A strategic approach to regulating new antimicrobials.Journal of global health · 2025
   Article
6. Distribution and Determinants of Antibiotic Self-Medication: A Cross-Sectional Study in Chinese Residents.Antibiotics (Basel, Switzerland) · 2025
   Article
7. Implementing the Chinese mandatory antimicrobial stewardship program: barriers to continuous improvement.Health policy and planning · 2025
   Article
8. Prevalence, antibiotic resistance, resistance and virulence determinants ofOne health (Amsterdam, Netherlands) · 2025
   Review
9. Development of predictive nomogram for clinical use of special-grade antimicrobial agents in patients with diabetes foot infections.Frontiers in endocrinology · 2025
   Article
10. A complex intervention to reduce antibiotic prescribing in rural China: a cluster randomised controlled trial.The Lancet regional health. Western Pacific · 2024
    Article
11. Antibiotic prescription for children with acute respiratory tract infections in rural primary healthcare in Guangdong province, China: a cross-sectional study.BMJ open · 2023
    Article
12. Sales of antibiotics without a prescription in pharmacies, 2017 and 2021, China.Bulletin of the World Health Organization · 2023
    Article
13. The temporal dynamics of antimicrobial-resistantNational science review · 2023
    Article
14. Use of antibiotics and other treatments in Chinese adults with acute cough: An online survey.Integrative medicine research · 2023
    Article
15. Long-term trend of antibiotic use at public health care institutions in northwest China, 2012-20 -- a case study of Gansu Province.BMC public health · 2023
    Article
16. The public's antibiotic use behavioural patterns and their determinants for upper respiratory tract infections: a latent class analysis based on consumer behaviour model in China.Frontiers in public health · 2023
    Article
17. Trends and Patterns of Antibiotic Prescriptions in Primary Care Institutions in Southwest China, 2017-2022.Infection and drug resistance · 2023
    Article
18. Patterns and Determinants of Antibiotic Use Behaviors among Rural Community Residents in Eastern China.Antibiotics (Basel, Switzerland) · 2022
    Article
19. Influence of Government Price Regulation on the Price, Volume and Spending of Antibiotics in China: A Controlled Interrupted Time Series Study.International journal of health policy and management · 2022
    Article
20. Antibiotic Stewardship in Retail Pharmacies and the Access-Excess Challenge in China: A Policy Review.Antibiotics (Basel, Switzerland) · 2022
    Review

Corrections and comments

• Comment on
  Antibiotic resistance in China--a major future challenge.2009

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as